300147.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 07:28):

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China...

Stats
Dzisiejszy wolumen	9.58M
Średni wolumen	20.32M
Kapitalizacja rynkowa	2.40B
EPS	CNY-0.155 ( 2023-06-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-6.28
ATR14	CNY0.00900 (0.25%)

Wolumen Korelacja

Długi: -0.12 (neutral)

Krótki: 0.86 (strong)

Signal:(52.794) Same movement expected

Xiangxue Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Xiangxue Pharmaceutical Korelacja - Waluta/Towar

-0.29
( neutral )

-0.59
( weak negative )

0.00
( neutral )

-0.62
( weak negative )

Xiangxue Pharmaceutical Finanse

Annual	2022
Przychody:	CNY2.19B
Zysk brutto:	CNY542.51M (24.81 %)
EPS:	CNY-0.770

FY	2022
Przychody:	CNY2.19B
Zysk brutto:	CNY542.51M (24.81 %)
EPS:	CNY-0.770

FY	2021
Przychody:	CNY2.97B
Zysk brutto:	CNY779.28M (26.23 %)
EPS:	CNY-1.049

FY	2020
Przychody:	CNY3.07B
Zysk brutto:	CNY992.57M (32.31 %)
EPS:	CNY0.150

Financial Reports:

No articles found.

Xiangxue Pharmaceutical

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. The company was founded in 1997 and is based in Guangzhou, China.